Long A, Rahmaoui A, Rothman KJ, Guinan E, Eisner M, Bradley MS, Iribarren C, Chen H, Carrigan G, Rosén K, Szefler S. Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab. J Allergy Clin Immunol Pract. 2014 Sep;134(3):560-567.e. doi: 10.1016/j.jaci.2014.02.007
Donnelly DW, Hegarty A, Sharp L, Carsin AE, Deady S, McCluskey N, Comber H, Gavin A. The impact of adjustment for socioeconomic status on comparisons of cancer incidence between two European countries. J Cancer Epidemiol. 2013 Jan 1;2013:612514. doi: 10.1155/2013/612514
Hirst C, Castellsague J, Calingaert B, Stanford RH. Asthma exacerbations associated with inhaled corticosteroid/long-acting beta-agonists or other inhaled corticosteroid regimens in pediatrics: meta-analysis of observational studies. J Allergy Clin Immunol Pract. 2010 Feb 1;125(2):AB71.
Arellano FM, Arana A, Wentworth CE, Fernández-Vidaurre C C, Schlienger RG, Conde E. Lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United Kingdom. J Allergy Clin Immunol Pract. 2009;123(5):111-6-116.
Santanello NC, Demuro-Mercon C, Davies G, Ostrom N, Noonan M, Rooklin A, Knorr B. Validation of a pediatric asthma caregiver diary. J Allergy Clin Immunol Pract. 2000 Nov 1;106(5):861-6.